Results

Total Results: 67 records

Showing results for "higher".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation_Guide_Prediabetes_and_Type_2_Diabetes_Part_One_Screening.pdf
    September 01, 2022 - The prevalence of diabetes for people living in this area is higher than the national norm, often characteristic … Additionally, they note that “[t]he prevalence of diabetes is higher among American Indian/Alaska Native … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher
  2. cds.ahrq.gov/sites/default/files/cds/artifact/1061/508_2022_CDS_Connect_IG_T2DM_Part_One_Screening_final.pdf
    January 01, 2022 - The prevalence of diabetes for people living in this area is higher than the national norm, often characteristic … Additionally, they note that “[t]he prevalence of diabetes is higher among American Indian/Alaska Native … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher
  3. cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_Intervention_Content_T2DM_Part_Two_Counseling.xlsx
    January 01, 2023 - pregnant (gestational diabetes) or polycystic ovarian syndrome (a condition where the ovaries produce higher-than-normal
  4. cds.ahrq.gov/sites/default/files/cds/artifact/1066/2022_Intervention_Content_T2DM_Counseling.xlsx
    January 01, 2022 - pregnant (gestational diabetes) or polycystic ovarian syndrome (a condition where the ovaries produce higher-than-normal
  5. cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20One,%20Screening_Final.pdf
    September 01, 2019 - The prevalence of diabetes for people living in this area is higher than the national norm, often characteristic … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher
  6. cds.ahrq.gov/sites/default/files/cds/artifact/1071/Implementation%20Guide_Healthful%20Diet%20and%20Physical%20Activity_Final.pdf
    September 01, 2019 - The prevalence of CVD for people living in this area is higher than the national norm. … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher
  7. cds.ahrq.gov/sites/default/files/cds/artifact/1061/IG%20Abnormal%20Blood%20Glucose%20Type%202%20DM%20Screening.pdf
    September 01, 2021 - The prevalence of diabetes for people living in this area is higher than the national norm, often characteristic … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher
  8. cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
    March 01, 2018 - Agency for Healthcare Research and Quality (AHRQ) is to produce evidence to make healthcare safer, higher … This ensured that only the Grade B recommendation or higher would be considered for the response.
  9. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
    January 01, 2020 - The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … combination not be initiated.”26 The ACC further states, “People with chronic kidney disease are at higher
  10. cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2023 - The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … The ACC further states, “People with chronic kidney disease are at higher risk of side effects from
  11. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
    September 01, 2022 - The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … combination not be initiated.”25 The ACC further states “People with chronic kidney disease are at higher
  12. cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2017.pdf
    January 01, 2017 - Agency for Healthcare Research and Quality (AHRQ) is to produce evidence to make health care safer, higher … In addition, implementation guides can be useful to convey higher-level information on the relationship
  13. cds.ahrq.gov/sites/default/files/cds/artifact/1066/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20Two%20Counseling_Final.pdf
    September 01, 2019 - overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher
  14. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
    April 01, 2021 - The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … combination not be initiated.”26 The ACC further states, “People with chronic kidney disease are at higher
  15. cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final.pdf
    September 01, 2019 - The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … combination not be initiated.”31 The ACC further states, “People with chronic kidney disease are at higher
  16. cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_CDS_Connect_IG_T2DM_Part_Two_Counseling_0.pdf
    January 01, 2023 - overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher … overweight” as a BMI of 25 kg/m2 or greater and less than 30 kg/m2, and “obese” as a BMI of 30 kg/m2 or higher
  17. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … combination not be initiated.”30 The ACC further states “People with chronic kidney disease are at higher
  18. cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
    October 01, 2017 - the score could be caveated to indicate that the individual has FH; therefore, the true score may be higher
  19. cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - the score could be caveated to indicate that the individual has FH; therefore, the true score may be higher
  20. cds.ahrq.gov/sites/default/files/cds/artifact/1071/Implementation_Guide_Healthy_Diet_and_Physical_Activity.pdf
    September 01, 2022 - The prevalence of CVD for people living in this area is higher than the national norm. … A score of 7.5% or higher satisfies the inclusion criteria for this artifact.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: